Evaluation and Treatment of Adhesive Capsulitis Using Non-invasive Neurostimulation Devices

Launched by UNIVERSITÉ DU QUÉBEC À CHICOUTIMI · Jan 27, 2025

Keywords

ClinConnect Summary

This clinical trial is looking at a condition called adhesive capsulitis, commonly known as frozen shoulder, which can cause pain and limit movement in the shoulder. The study aims to understand how the brain processes sensations in people with this condition compared to healthy individuals. Researchers will also test a new treatment using vibration to see if it helps improve movement and reduce pain more effectively than a placebo (a fake treatment). Participants will be divided into groups, with some receiving the real treatment and others receiving a non-effective version, both while doing specific exercises.

To be eligible for the study, participants need to be at least 18 years old and in good health. They should either have a diagnosis of frozen shoulder or have no shoulder pain at all. Those with certain health issues, like cognitive disorders or neurological diseases, will not be able to participate. Throughout the trial, participants can expect to complete questionnaires, undergo physical assessments, and receive the treatment over several sessions. This study is important because it aims to provide new insights into adhesive capsulitis and explore innovative ways to help those affected by it.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 18 years old and over
• • Good general health
• • Adhesive capsulitis (experimental group) or
• • No shoulder pain (placebo group)
• Exclusion Criteria:
• • Cognitive disorders;
• • Any neurological disease/injury affecting the upper limbs;
• • History or diagnosis of muscle, tendon, or capsular tear;
• • Shoulder surgery/prosthesis;
• • Pregnant woman;
• • Presence of metal in the skull or jaw;
• • History of epilepsy.